Boult Wade Tennant
Bulletins » Change to compliance period of UK divisional applications.

The way of determining the compliance period of a UK divisional application is changing on 1 May 2023. From 1 May 2023 a newly-filed divisional application will be accorded a compliance period which is the same as the original and un-extended compliance period of the original parent application (i.e. the original UK application at the top of the family tree). This may constrain the filing of cascading divisionals, but if no extensions to the compliance period have been obtained on the original parent application, then you will not see any difference following this rule change.

The compliance period is the period for putting an application in order for allowance (i.e. at the end of the period, the application must be in a form that the UKIPO is willing to grant or it is refused). Up until now, the UKIPO has accorded UK divisional applications the same compliance period as the direct parent application. Therefore, currently, if the parent application’s compliance deadline had been extended, then that same extended deadline would be applied to the new divisional.

Limited extensions to the compliance period of both the parent and the divisional applications will still be available under Rule 108 in the normal way.  Separate requests for extensions will, however, need to be made for the divisional versus the parent.

From 1 May 2023, the UKIPO will give a UK divisional application filed on or after that date a compliance period of:

  • four years and six months beginning immediately after the priority date (or the filing date if there is no priority date); or
  • if it expires later, a period of twelve months beginning immediately after the date on which the first substantive examination report is sent to the applicant, in relation to the earlier (parent) application.

The change can therefore have an impact on cascading divisionals which will now be more time-constrained. Any divisional will take the original non-extended compliance period of the original parent application. For example, a second-generation divisional will have the non-extended compliance deadline of the grandparent UK application, and not the parent (first generation divisional) from which it is filed.

We recommend contacting your Boult Representative if you have any questions about your UK application(s), and particularly about the filing of any UK divisional applications.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications